>
pdufa.bio

GTX-102

Updated ยทnext FDA decision on the calendar

GTX-102 is a Ultragenyx Pharmaceutical Inc. program. Every date links its source.

RARE catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Ultragenyx Pharmaceutical Inc. (RARE). We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jul 2026RARE

Questions

When is GTX-102's next FDA decision or readout?

No upcoming catalyst is on our calendar for GTX-102; no FDA decisions are on record below.

What happened at GTX-102's most recent FDA decision?

No FDA decision for GTX-102 is in our archive yet.

Who makes GTX-102?

Ultragenyx Pharmaceutical Inc. (RARE).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.